C. Biojone
发表
E. Castrén,
Cecilia Cannarozzo,
S. M. Fred,
2019,
bioRxiv.
C. Gouvêa,
C. Biojone,
A. Miranda,
2018,
Applied Biochemistry and Biotechnology.
E. Castrén,
C. Normann,
C. Bramham,
2019,
Cell.
E. Castrén,
Cecilia Cannarozzo,
S. M. Fred,
2022,
bioRxiv.
E. Castrén,
S. Joca,
C. Becari,
2018,
Molecular Neurobiology.
E. Castrén,
M. C. Salgado,
C. Becari,
2017,
Molecular Neurobiology.
E. Castrén,
C. Becari,
C. Biojone,
2022
.
E. Castrén,
C. Normann,
C. Bramham,
2019
.
G. Wegener,
S. Joca,
D. Ribeiro,
2019
.
E. Castrén,
Cecilia A Brunello,
Cecilia Cannarozzo,
2022,
bioRxiv.
C. Biojone,
F. Guimarães,
S. Joca,
2010,
British journal of pharmacology.
F. Corrêa,
A. Scopinho,
C. Biojone,
2014,
Neuroscience.
H. Steinbusch,
J. Mill,
K. Lunnon,
2014,
Molecular Neurodegeneration.
J. Tanus-Santos,
F. Guimarães,
S. Joca,
2019,
Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Activation of the TRKB receptor mediates the panicolytic-like effect of NOS inhibitor aminoguanidine
D. Ribeiro,
H. Zangrossi,
C. Biojone,
2018,
bioRxiv.
E. Castrén,
S. Joca,
S. M. Fred,
2017,
Neuropharmacology.
G. Kenis,
C. Fitzsimons,
M. Boks,
2014
.
A. H. Betti,
L. Müller,
S. Joca,
2019,
Behavioural pharmacology.
F. Guimarães,
M. S. Terceti,
S. Joca,
2011,
British journal of pharmacology.
E. Castrén,
J. Partanen,
P. Piepponen,
2020,
The Journal of Neuroscience.
E. Castrén,
F. Winkel,
J. Umemori,
2020,
The Journal of Neuroscience.
F. Guimarães,
V. Fattori,
W. Verri,
2018,
Journal of Neuroimmunology.
F. Guimarães,
R. Andreatini,
D. Correia,
2013,
Fundamental & clinical pharmacology.
E. Castrén,
S. M. Fred,
C. Biojone,
2023,
Progress in Neurobiology.
F. Corrěa,
C. Crestani,
L. Resstel,
2013,
European journal of pharmacology.
F. Guimarães,
F. Moreira,
C. Biojone,
2010
.
E. Castrén,
T. Rantamäki,
C. Biojone,
2018,
bioRxiv.
E. Castrén,
C. Normann,
C. Bramham,
2019,
bioRxiv.
F. Guimarães,
F. Ferreira,
S. Joca,
2008,
Behavioural pharmacology.
F. Guimarães,
S. Joca,
C. Biojone,
2017,
Acta Neuropsychiatrica.
F. Guimarães,
S. Joca,
H. Zangrossi,
2011,
Behavioural Brain Research.
E. Castrén,
C. Biojone,
P. Casarotto,
2021,
bioRxiv.
E. Castrén,
S. Joca,
C. Biojone,
2015,
CNS & neurological disorders drug targets.
S. Joca,
C. Biojone,
A. Sales,
2014,
Behavioural pharmacology.
F. Guimarães,
S. Joca,
C. Biojone,
2020
.
L. Resstel,
F. Corrêa,
C. Biojone,
2014,
European Neuropsychopharmacology.
G. Eichenberger,
N. Coimbra,
C. Jucá,
2000,
Psychopharmacology.
F. Guimarães,
F. Moreira,
H. Zangrossi,
2011,
Journal of psychopharmacology.
G. Wegener,
D. Ribeiro,
S. Joca,
2019,
PeerJ.
F. Guimarães,
R. Pobbe,
G. Lucas,
2015,
European Neuropsychopharmacology.
E. Castrén,
C. Normann,
C. Bramham,
2023
.
E. Castrén,
M. Varjosalo,
K. Mineev,
2023,
Nature Neuroscience.
Inhibition of iNOS induces antidepressant-like effects in mice: Pharmacological and genetic evidence
F. Guimarães,
F. Cunha,
S. Lisboa,
2012,
Neuropharmacology.
E. Castrén,
S. Joca,
C. Biojone,
2020,
bioRxiv.
C. Biojone,
F. Guimarães,
S. Joca,
2010,
British journal of pharmacology.
F. Guimarães,
R. Pobbe,
G. Lucas,
2015,
European Neuropsychopharmacology.
J. Tanus-Santos,
H. Zangrossi,
C. Biojone,
2022
.
K. Lunnon,
D. Mastroeni,
P. Lucassen,
2014
.
V. Fattori,
A. C. Issy,
S. Lisboa,
2018,
Journal of Neuroimmunology.
C. Biojone,
S. Joca,
Matti Bock Guldager,
2024,
Progress in Neuro-Psychopharmacology and Biological Psychiatry.